Cargando…

The Protective Role of Immunomodulators on Tissue-Type Plasminogen Activator-Induced Hemorrhagic Transformation in Experimental Stroke: A Systematic Review and Meta-Analysis

Background: Recanalization with tissue plasminogen activator (tPA) is the only approved agent available for acute ischemic stroke. But delayed treatment of tPA may lead to lethal intracerebral hemorrhagic transformation (HT). Numerous studies have reported that immunomodulators have good efficacy on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Yang, Zhu, Yu-Tian, Tong, Hong-Xuan, Han, Jing-Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793743/ https://www.ncbi.nlm.nih.gov/pubmed/33424615 http://dx.doi.org/10.3389/fphar.2020.615166

Ejemplares similares

QiShenYiQi Inhibits Tissue Plasminogen Activator–Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice
por: Ye, Yang, et al.
Publicado: (2022)

The Role of Matrix Metalloproteinases in Hemorrhagic Transformation in the Treatment of Stroke with Tissue Plasminogen Activator
por: Babenko, Valentina A., et al.
Publicado: (2023)

Therapeutic Strategies to Attenuate Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment for Acute Ischemic Stroke
por: Kanazawa, Masato, et al.
Publicado: (2017)

A Canine Model of Hemorrhagic Transformation Using Recombinant Tissue Plasminogen Activator Administration After Acute Ischemic Stroke
por: Jiang, Run-Hao, et al.
Publicado: (2019)

Neutrophilic noncoding RNAs predict outcomes of acute ischemic stroke patients treated with recombinant tissue plasminogen activator
por: Han, Ziping, et al.
Publicado: (2022)

Rosiglitazone ameliorates tissue plasminogen activator‐induced brain hemorrhage after stroke
por: Li, Yan, et al.
Publicado: (2019)

Genome response to tissue plasminogen activator in experimental ischemic stroke
por: Jickling, Glen C, et al.
Publicado: (2010)

Effects of Angiopoietin-1 on Hemorrhagic Transformation and Cerebral Edema after Tissue Plasminogen Activator Treatment for Ischemic Stroke in Rats
por: Kawamura, Kunio, et al.
Publicado: (2014)

Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
por: Keric, Naureen, et al.
Publicado: (2012)

Inhibition of Pathological Retinal Neovascularization by a Small Peptide Derived from Human Tissue-Type Plasminogen Kringle 2
por: Sun, Qian, et al.
Publicado: (2020)

Efficacy of Resveratrol in Experimental Subarachnoid Hemorrhage Animal Models: A Stratified Meta-Analysis
por: Tan, Jiahe, et al.
Publicado: (2022)

Anticoagulation Resumption in a Patient With Mechanical Heart Valves, Antithrombin Deficiency, and Hemorrhagic Transformation Following Thrombectomy After Ischemic Stroke
por: Li, Yi-Chen, et al.
Publicado: (2020)

Predictors of Intracerebral Hemorrhage in Acute Stroke Patients Receiving Intravenous Recombinant Tissue Plasminogen Activator
por: Chenna, Vijay, et al.
Publicado: (2018)

Alterations in the gut microbiome with hemorrhagic transformation in experimental stroke
por: Huang, Qin, et al.
Publicado: (2021)

Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage
por: Kunjukunju, Nancy, et al.
Publicado: (2011)

Centhaquine Restores Renal Blood Flow and Protects Tissue Damage After Hemorrhagic Shock and Renal Ischemia
por: Ranjan, Amaresh K., et al.
Publicado: (2021)

Hemorrhagic Transformation after Intravenous Tissue Plasminogen Activator Administration in Acute Distal Middle Cerebral Artery Occlusion
por: Lee, Chan-Hyuk, et al.
Publicado: (2022)

Tissue Plasminogen Activator Toxicity after Submacular Hemorrhage Repair
por: Islam, Yasmin, et al.
Publicado: (2021)

Combined Treatment With 2-(2-Benzofu-Ranyl)-2-Imidazoline and Recombinant Tissue Plasminogen Activator Protects Blood–Brain Barrier Integrity in a Rat Model of Embolic Middle Cerebral Artery Occlusion
por: Zhang, Linlei, et al.
Publicado: (2020)

The Role of Hydrogen Sulfide on Cardiovascular Homeostasis: An Overview with Update on Immunomodulation
por: Pan, Li-Long, et al.
Publicado: (2017)

Nanoscale Diamond-Based Formulation as an Immunomodulator and Potential Therapeutic for Lymphoma
por: Paladhi, Ankush, et al.
Publicado: (2022)

Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance
por: Liu, Dong-Ling, et al.
Publicado: (2021)

Viral delivery of a peptide-based immunomodulator enhances T cell priming during vaccination
por: Phares, Timothy W., et al.
Publicado: (2022)

Management of Pediatric Strokes With Alteplase (Tissue Plasminogen Activator)
por: Filatov, Asia, et al.
Publicado: (2021)

Systematic Review of Host-Mediated Activity of Miltefosine in Leishmaniasis through Immunomodulation
por: Palić, Semra, et al.
Publicado: (2019)

Validation of an Instrument for Measuring Adherence to Treatment With Immunomodulators in Patients With Multiple Myeloma
por: Silveira, Lívia Pena, et al.
Publicado: (2021)

Urokinase vs Tissue-Type Plasminogen Activator for Thrombolytic Evacuation of Spontaneous Intracerebral Hemorrhage in Basal Ganglia
por: Li, Yuqian, et al.
Publicado: (2017)

No Influence of Dabigatran Anticoagulation on Hemorrhagic Transformation in an Experimental Model of Ischemic Stroke
por: Bohmann, Ferdinand, et al.
Publicado: (2012)

Tissue Plasminogen Activator-Assisted Vitrectomy for Ruptured Eye with Suprachoroidal Hemorrhage
por: Matsumoto, Koichi, et al.
Publicado: (2012)

Outcomes of asymptomatic recombinant tissue plasminogen activator associated intracranial hemorrhage
por: Teekaput, Chutithep, et al.
Publicado: (2022)

Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke
por: Gautier, Sophie, et al.
Publicado: (2014)

Evaluation of Prognostic Values of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Crimean-Congo Hemorrhagic Fever Patients
por: Gurbuz, Yunus, et al.
Publicado: (2015)

Hemorrhagic Transformation of Ischemic Strokes
por: Kovács, Kitti Bernadett, et al.
Publicado: (2023)

Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke
por: Huang, Yuyou, et al.
Publicado: (2023)

Frequency and determinants for hemorrhagic transformation of posterior cerebral stroke: Posterior ischemic stroke and hemorrhagic transformation
por: Valentino, Francesca, et al.
Publicado: (2017)

Key Phytochemicals and Biological Functions of Chuanxiong Rhizoma Against Ischemic Stroke: A Network Pharmacology and Experimental Assessment
por: Zeng, Peng, et al.
Publicado: (2021)

Different Doses of Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: A Network Meta-Analysis
por: Li, Bing-Hu, et al.
Publicado: (2022)

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis
por: Wardlaw, Joanna M, et al.
Publicado: (2012)

Heme oxygenase-1 in pregnancy and cancer: similarities in cellular invasion, cytoprotection, angiogenesis, and immunomodulation
por: Zhao, Hui, et al.
Publicado: (2015)

Clinical and Experimental Immunomodulation
por: Pavón, Lenin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cqff8qf7dr8oif8vie48ovb87k